FINWIRES · TerminalLIVE
FINWIRES

Ryman Healthcare Mulls Six-Year Fixed-Rate Secured Bond Offer

By

Ryman Healthcare (ASX:RYM, NZE:RYM) said it is evaluating a proposed issuance of six-year fixed-rate, secured and unsubordinated bonds to institutional and New Zealand retail investors, backed by a guarantee and security package from its guaranteeing group, according to a Wednesday filing with the Australian and New Zealand bourses.

Existing holders of the company's RYM010 quoted bonds in custodial accounts may exchange some or all holdings into the new bonds at par on a one-for-one basis, subject to allocation and approval by the company and the relevant bookbuild participant, per the filing.

Exchanged bonds will be cancelled, reducing RYM010 supply, and trading is expected to be temporarily suspended during the new bonds' rate-setting and initial quotation period, the filing said.

The offer is anticipated to open in the week commencing June 8, subject to a successful bookbuild, the filing added.

Related Articles

Asia

Cygnus Metals to Be Acquired by Central Asia Metals in AU$232 Million All-Scrip Deal

Cygnus Metals (ASX:CY5) agreed to be acquired by Central Asia Metals in an all-scrip deal that values each Cygnus share at AU$0.176, implying an equity value for the company of around AU$232 million, according to a late Tuesday filing with the Australian bourse.Under a definitive scheme implementation deed, Cygnus shareholders will receive 0.06 new Central Asia Metals share for each Cygnus share held.Existing Central Asia Metals shareholders will own about 70% of the company's enlarged fully diluted issued share capital after the deal, while Cygnus shareholders will own the remaining 30%.The transaction will give Central Asia Metals a flagship development-stage asset through a 100% interest in Canada's Chibougamau copper-gold project.

$ASX:CY5
Asia

Scales Declares Final Dividend for 2025

Scales (NZE:SCL) declared a final dividend of NZ$0.125 per share for full year 2025, payable on July 9 to shareholders of record as of June 25, according to a Wednesday filing with the New Zealand bourse.The company paid a dividend of NZ$0.0775 per share in the prior corresponding period, an earlier filing showed.

$NZE:SCL
Asia

Telix Pharmaceuticals, United Imaging Healthcare Sign MOU for US Theranostics Collaboration

Telix Pharmaceuticals (ASX:TLX) and United Imaging Healthcare North America entered into a memorandum of understanding (MOU) to evaluate a strategic research partnership in the US focused on developing integrated theranostics technologies that combine diagnostics and targeted therapy, Telix said Tuesday after hours.The partnership will evaluate integrating United Imaging's imaging systems, software, connectivity, and artificial intelligence (AI) tools with the company's molecular imaging portfolio and clinical protocols to enhance theranostic workflows.Key focus areas include improving integration of imaging and radiopharmaceutical workflows, standardizing protocol-driven imaging across sites, enhancing treatment planning and patient monitoring, and developing AI-enabled clinical decision support tools.The initial focus will be on TLX101-Px, a positron emission tomography imaging candidate, with opportunities to expand into additional products and markets, as well as pilot programs and protocol optimization efforts.

$ASX:TLX